Abstract
Background
Graphene oxide nanosheets (GONS) are recognized for their role in enhancing drug delivery and effectiveness in cancer treatment. With colon cancer being a prevalent global issue and the significant side effects associated with chemotherapy, the primary treatment for colon cancer alongside surgery, there is a critical need for novel therapeutic strategies to support patients in combating this disease. Hesperetin (HSP), a natural compound found in specific fruits, exhibits anti-cancer properties. The aim of this study is to investigate the effect of GONS on the LS174t colon cancer cell line.
Methods
In this study, an anti-cancer nano-drug was synthesized by creating a hesperetin-graphene oxide nanocomposite (Hsp-GO), which was subsequently evaluated for its efficacy through in vitro cell toxicity assays. Three systems were investigated: HSP, GONS, and HSP-loaded GONS, to determine their cytotoxic and pro-apoptotic impacts on the LS174t colon cancer cell line, along with assessing the expression of BAX and BCL2. The morphology and properties of both GO and Hsp-GO were examined using scanning electron microscopy (SEM), X-ray diffraction, and Fourier transform infrared spectroscopy (FTIR).
Results
The Hsp-GO nanocomposite displayed potent cytotoxic and pro-apoptotic effects on LS174t colon cancer cells, outperforming individual treatments with HSP or GONS. Cell viability assays showed a significant decrease in cell viability with Hsp-GO treatment. Analysis of BAX and BCL2 expression revealed elevated BAX and reduced BCL2 levels in Hsp-GO treated cells, indicating enhanced apoptotic activity. Morphological analysis confirmed successful Hsp-GO synthesis, while structural integrity was supported by X-ray diffraction and FTIR analyses.
Conclusions
These study highlight the potential of Hsp-GO as a promising anti-cancer nano-drug for colon cancer therapy.
Similar content being viewed by others
Data availability
All data analyzed during this study are included in this published article. Further raw data from the current study are available from the corresponding author upon request.
References
Chen S, Shen X (2020) Long noncoding RNAs: functions and mechanisms in colon cancer. Mol Cancer 19(1):167. https://doi.org/10.1186/s12943-020-01287-2
Altalebi SAR, Haghi M, Hosseinpour Feizi MA (2023) Expression study of microRNA cluster on chromosome 19 (C19MC) in tumor tissue and serum of breast cancer patient. Mol Biol Rep 50(12):9825–9831. https://doi.org/10.1007/s11033-023-08801-x
Rasool AA, Haghi M, Hosseinpour Feizi MA (2023) Study of MicroRNA Cluster Located on Chromosome X in Serum and Breast Cancer Tissue. Biochemical genetics, https://doi.org/10.1007/s10528-023-10448-z. Advance online publication.
Haghi M, Ranjbar M, Karari K, Samadi-Miandoab S, Eftekhari A, Hosseinpour-Feizi MA (2021) Certain haplotypes of the 3’-UTR region of the HLA-G gene are linked to breast cancer. Br J Biomed Sci 78(2):87–91. https://doi.org/10.1080/09674845.2020.1856495
Alsadooni JFK, Haghi M, Barzegar A, Feizi MAH (2023) The effect of chitosan hydrogel containing gold nanoparticle complex with paclitaxel on colon cancer cell line. Int J Biol Macromol 247:125612. https://doi.org/10.1016/j.ijbiomac.2023.125612
Lombardi L, Morelli F, Cinieri S, Santini D, Silvestris N, Fazio N, Orlando L, Tonini G, Colucci G, Maiello E (2010) Adjuvant colon cancer chemotherapy: where we are and where we’ll go. Cancer Treat Rev 36(Suppl 3):S34–S41. https://doi.org/10.1016/S0305-7372(10)70018-9
Heydarnezhad Asl M, Ahmadi A, Karari K, Haghi M, Tohidkia MR et al (2022) Anti-proliferative effects of Ocimum basilicum Leaf Aqueous extract on Colon cancer cell lines and the expression of apoptotic genes. Jentashapir J Cell Mol Biol 13(1):e123890. https://doi.org/10.5812/jjcmb-123890
Lewinsohn E, Britsch L, Mazur Y, Gressel J (1989) Flavanone Glycoside Biosynthesis in Citrus: Chalcone synthase, UDP-Glucose:Flavanone-7-O-Glucosyl-Transferase and -rhamnosyl-transferase activities in cell-free extracts. Plant Physiol 91(4):1323–1328. https://doi.org/10.1104/pp.91.4.1323
Sohel M, Sultana H, Sultana T, Al Amin M, Aktar S, Ali MC, Rahim ZB, Hossain MA, Mamun A, Amin A, M. N., Dash R (2022) Chemotherapeutic potential of hesperetin for cancer treatment, with mechanistic insights: a comprehensive review. Heliyon 8(1):e08815. https://doi.org/10.1016/j.heliyon.2022.e08815
Shim G, Kim MG, Park JY, Oh YK (2016) Graphene-based nanosheets for delivery of chemotherapeutics and biological drugs. Adv drug Delivery Reviews 105(Pt B) 205–227. https://doi.org/10.1016/j.addr.2016.04.004
Zhang S, Sunami Y, Hashimoto H, Basel (2017) Mini review: nanosheet technology towards biomedical application. Nanomater, 7(9), 246. https://doi.org/10.3390/nano7090246
Tabish TA, Pranjol MZI, Hayat H, Rahat AAM, Abdullah TM, Whatmore JL, Zhang S (2017) In vitro toxic effects of reduced graphene oxide nanosheets on lung cancer cells. Nanotechnology 28(50):504001. https://doi.org/10.1088/1361-6528/aa95a8
Zarebczan B, Pinchot SN, Kunnimalaiyaan M, Chen H (2011) Hesperetin, a potential therapy for carcinoid cancer. Am J Surg 201(3):329–333. https://doi.org/10.1016/j.amjsurg.2010.08.018
Yang Y, Wolfram J, Boom K, Fang X, Shen H, Ferrari M (2013) Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells. Cell Biochem Funct 31(5):374–379. https://doi.org/10.1002/cbf.2905
Loutfy SA, Salaheldin TA, Ramadan MA, Farroh KhY, Abdallah ZF, Youssef T (2017) Synthesis, characterization and cytotoxic evaluation of Graphene Oxide nanosheets: in Vitro Liver Cancer Model. Asian Pac J cancer Prevention: APJCP 18(4):955–961. https://doi.org/10.22034/APJCP.2017.18.4.955
Xie M et al (2018) Surface modification of graphene oxide nanosheets by protamine sulfate/sodium alginate for anti-cancer drug delivery application. Appl Surf Sci 440:853–860. https://doi.org/10.1016/j.apsusc.2018.01.175
Mohanta YK et al (2021) Development of graphene oxide nanosheets as potential biomaterials in cancer therapeutics: an in-vitro study against breast cancer cell line. 31(11):4236–4249
Pham TT et al (2019) Targeted delivery of doxorubicin for the treatment of bone metastasis from breast cancer using alendronate-functionalized graphene oxide nanosheets. 76:310–317
Shafiee A, Iravani S, Varma RS (2022) Graphene and graphene oxide with anticancer applications: challenges and future perspectives. MedComm 3(1):e118. https://doi.org/10.1002/mco2.118
Kregielewski K, Fraczek W, Grodzik M (2023) Graphene Oxide enhanced cisplatin cytotoxic effect in Glioblastoma and Cervical Cancer. Molecules 28(17):6253. https://doi.org/10.3390/molecules28176253
Rahmani AH, Babiker AY, Anwar S (2023) Hesperidin, a Bioflavonoid in Cancer Therapy: a review for a mechanism of action through the modulation of Cell Signaling pathways. Molecules (Basel Switz 28(13):5152. https://doi.org/10.3390/molecules28135152
Seetharaman PK, Sivapunniyam A, Ramalingam P, Karthik (2023) Fabrication of a citrus flavonoid hesperetin-capped gold nanoparticles-reduced graphene oxide nanocomposites (Hes-Au/rGONCs) as a potential therapeutic agent for triple negative breast cancer and bacterial infections. Surf Interfaces 42. https://doi.org/10.1016/j.surfin.2023.103347
Acknowledgements
Not applicable.
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
A.S. Experimented and wrote the manuscript with support from M.H. and. MA.H. supervised the work and contributed to the design and implementation of the research, the analysis of the results, and the writing of the manuscript. A.B. Prepration of Nanoparticle and analysis. All authors discussed the results and contributed and reviewed the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
It may not be directly applicable but this study was approved by the Department of Biology committee at the University of Tabriz (14001102).
Competing interests
The authors confirm that there are no known conflicts of interest associated with this publication, and there has been no significant financial support for this work that could have influenced its outcome.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hadi, A.S., Haghi, M., Barzegar, A. et al. Comparative evaluation of hesperetin-loaded graphene oxide nanosheets (Hsp-GO) as a drug delivery system for colon cancer: synthesis and anticancer efficiency assessment. Mol Biol Rep 51, 591 (2024). https://doi.org/10.1007/s11033-024-09504-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11033-024-09504-7